Karolin Wagner is a PhD student at the Technical University of Munich. She started her studies of Biology at the University of Cologne and followed a strong focus on immunology. After her master studies, she joined the lab of Prof. Dirk Busch in Munich. Their work is primarily focused on antigen-specific T cell responses and T cell engineering. Besides her PhD focus on adoptive T cell therapy in the tumor setting, she shifted her focus early in the pandemic and initiated a SARS-CoV-2 project.